ArticlePloS one2026

Cost-effectiveness of inclisiran in patients with atherosclerotic cardiovascular disease from Chinese healthcare perspective.

Mochou Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.